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ABSTRACT
Arsenic exposure is associated with lung cancer. Angiogenesis is essential for tumor development. However,
the role and mechanism of human vascular endothelial cells in tumor growth and angiogenesis induced by
arsenic-transformed bronchial epithelial (As-T) cells remain to be elucidated. In this study, we found that
endothelial cells significantly increased As-T cell-induced tumor growth compared to those induced by As-T cells
alone. To understand the molecular mechanism, we found that endothelial cells co-cultured with As-T cells or
cultured in conditioned medium (CM) prepared from As-T cells showed much higher cell migration,
proliferation, and tube formation compared to those co-cultured with BEAS-2B (B2B) cells or cultured in CM
from B2B. We identified that higher levels of intracellular interleukin 8 (IL-8) were secreted by As-T cells, which
activated IL-8/IL-8R signaling to promote endothelial cells migration and tube formation. IL-8 silencing and
knockout (KO) in As-T cells, or IL-8 neutralizing antibody dramatically suppressed endothelial cell proliferation,
migration, tube formation in vitro, and tumor growth and angiogenesis in vivo, suggesting a key role of IL-8 in
As-T cells to induce angiogenesis via a paracrine effect. Finally, blocking of IL-8 receptors C-X-C chemokine
receptor type 1 (CXCR1) and CXCR2 with neutralizing antibodies and chemical inhibitors inhibited tube
formation, indicating that IL-8Rs on endothelial cells are necessary for As-T cell-induced angiogenesis. Overall,
this study reveals an important molecular mechanism of arsenic-induced carcinogenesis, and suggests a new
option to prevent and treat arsenic-induced angiogenesis.

INTRODUCTION

pesticides [2–4]. Arsenic exposure is a major public
health concern and is associated with various diseases
such as diabetes mellitus, hypertension, and
cardiovascular diseases. Arsenic is also a welldocumented carcinogen, and long-term exposure to
arsenic is associated with lung, skin, urinary bladder,
kidney, and liver cancers [5–7]. It has been reported that
arsenic induces DNA damage by producing reactive
oxygen and nitrogen species and changes gene
expression via epigenetic mechanisms such as DNA
methylation and histone modification [6, 8], which are

Arsenic is one of the most abundant and widely
distributed semi-metallic elements in the crust of the
earth. Humans are exposed to arsenic mainly through
drinking inorganic arsenic-contaminated water, and
inhalation and skin contact are also important ways [1,
2]. Mining is the predominant source of arsenic
pollution, and the occupational exposure is mainly
through industrial manufactures such as wood
preservatives, mining activities, metal processing, and
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closely related to arsenic-induced cancer. However, the
mechanisms of arsenic-caused carcinogenesis still
remain to be elucidated.

angiogenesis through IL-8. In the present study, we
found that As-T cells and vascular endothelial cell
interaction promoted tumor growth and angiogenesis.
As-T cells generated more IL-8 to promote tumor
angiogenesis through its paracrine effect; and IL-8
receptors, C-X-C chemokine receptor type 1 (CXCR1),
and CXCR2, are required for As-T cells to induce
endothelial cell proliferation, migration, and tube
formation, thus enhancing tumor angiogenesis. This
study sheds light on the important mechanism of
microenvironmental crosstalk between arsenic-induced
malignant transformed cells and vascular endothelial
cells in mediating tumor angiogenesis and will be
helpful to develop interventions targeting the IL-8
paracrine pathway to prevent and treat arsenic-induced
lung cancer development in the future.

Angiogenesis, a process of generating new blood
vessels via sprouting of pre-existing vasculature, is
essential for tumor growth, invasion, and metastasis
through transporting nutrients, oxygen, metabolites, and
growth factors to the tumor. When tumors grow up to
about 2 mm in diameter, they can no longer obtain
enough oxygen and nutrients from surrounding
environments simply by diffusion [9, 10]. Therefore,
tumor angiogenesis is critical for further growth and
progression of the tumor. Increased angiogenesis has
been observed by arsenic exposure [11]. However, most
of the current studies focus on the direct effect of
arsenic on tumor angiogenesis or on the activity of
endothelial cells by studying the transformed cells or
vascular endothelial cells alone [12–14]. Notably, how
arsenic-induced transformed bronchial epithelial
(named As-T) cells trigger and maintain angiogenesis is
poorly understood in arsenic-caused lung cancer.

RESULTS
Human endothelial cells greatly promoted As-T cells
to induce tumor growth
Angiogenesis is essential for tumor growth, and
activation of quiescent endothelial cells is the initial
step of new blood vessel formation [25]. In order to
study whether human vascular endothelial cells promote
As-T cells to induce tumor growth, As-T cells were
mixed with or without human dermal microvascular
endothelial cells (HMVECs) in the presence of
Matrigel, seeded into biodegradable sponges, and
transplanted onto the chicken chorioallantoic membrane
(CAM) to grow the tumor for 11 days. We found that
the presence of HMVECs significantly increased tumor
growth induced by As-T cells by more than 2-fold when
compared to those tumors formed by As-T cells alone
(Figure 1), indicating that endothelial signaling
pathway(s) of HMVECs plays an important role in
enhancing tumor growth.

The tumor microenvironment includes vasculature,
cancer-associated fibroblasts (CAFs), extracellular
matrix (ECM), and infiltrating immune cells, and their
interaction with cancer cells has been considered to play
an important role in cancer initiation, promotion, and
progression [15, 16]. To trigger tumor angiogenesis,
cancer cells secrete high levels of pro-angiogenic
factors such as vascular endothelial growth factor
(VEGF), platelet-derived growth factor (PDGF), and
basic fibroblast growth factor (bFGF) into the tumor
microenvironment [3]. These factors can activate
quiescent endothelial cells of the surrounding blood
vessels to promote the formation of new blood vessels.
Extensive studies have demonstrated that the
interactions between cancer cells, immune cells and
vascular cells play key roles in promoting tumor growth
and angiogenesis [15–18]. However, how As-T cells
promote angiogenesis through modulating tumor
microenvironments is still largely unknown.

As-T cells increased cell migration and proliferation
of human umbilical vein cells (HUVECs) and
HMVECs
To investigate the molecular mechanism of vascular
endothelial cells to induce tumor growth, we cocultured immortalized human bronchial epithelial cells
BEAS-2B (B2B) or As-T cells with HUVECs
expressing green fluorescent protein (eGFP). We found
that co-culture of HUVECs with As-T cells increased
HUVECs proliferation on Day 4 and Day 5 by 2-fold
when compared to that of co-cultured HUVECs with
B2B cells (Figure 2A). Wound healing assay results
showed that co-culture with As-T cells also markedly
increased the migration ability of HUVECs by about
40% more wound closure (Figure 2B). Similarly, coculture of HMVECs with As-T cells significantly

Interleukin-8 (IL-8), a member of the chemokine
family, plays an important role in tumor growth,
angiogenesis, and metastasis [19]. Arsenic has been
shown to induce IL-8 upregulation in kidney cells [20],
arsenic-transformed urothelial cells [21], and arsenictransformed human bronchial epithelial (HBE) cells
[22]. Tumor microenvironmental IL-8 plays an
important role in promoting tumor angiogenesis in lung
cancer, colorectal cancer, and glioma [23] by directly
enhancing endothelial cell proliferation, survival, and
migration [24], but little information is known about
how crosstalk between arsenic-transformed cells and
vascular endothelial cells affects tumor growth and
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increased the cell proliferation (Figure 2C) and
migration ability (Figure 2D) of HMVECs compared to
co-culture with B2B cells. The results suggest that
transformed cells may secret more factors to activate
vascular endothelial cells and increase endothelial cell
migration and proliferation that are parts of the
angiogenesis process.

cells cultured in a basic EBM2 medium with 1% FBS
to reduce the growth factors. The HUVECs were
cultured in the CM for four days, and the cell viability
was determined by counting the number of living cells.
We found that compared to EBM2 with 1% FBS and
CM from B2B cells, the CM from As-T cells
significantly increased the growth of HUVECs
(Figure 3A). Furthermore, compared to the CM from
B2B, the CM from As-T cells dramatically promoted
the migration ability of both HUVECs and HMVECs,
showing more wound closure in the wound healing
assay and more transwelled cells in the transwell
migration assay (Figure 3B–3E). Consistent with these
results, we also found that As-T cells growing in
EBM2 with 1% FBS in the lower chamber attracted
more HUVECs to pass through the mesh
(Supplementary Figure 1). The tube formation assay
showed that HUVECs cultured in CM from As-T cells
formed better tubular structures with more number and
length of tubes, further confirming that the CM of As-T
cells may contain higher levels of angiogenic factors to

Vascular endothelial cells cultured in conditioned
medium (CM) from As-T cells showed higher cell
viability, more cell migration, and better tube
formation
Secretory factors, including growth factors and
cytokines, play important roles in the growth and
functions of vascular endothelial cells and are
important mediators in the tumor microenvironment for
the crosstalk between different types of cells. In order
to compare the effect of CM from normal and
transformed cells on vascular endothelial cellular
function, we collected the CM from B2B and As-T

Figure 1. Human endothelial cells greatly promoted As-T cells to induce tumor growth. As-T cells and human dermal

microvascular endothelial cells (HMVECs) were trypsinized, mixed in a 1:9 ratio with serum-free medium, and carried by the PLGA sponges
for the implantation onto the CAM of 8 days old chicken embryos. As-T cells alone were used as a control. The tumors were harvested 12
days after the implantation. (A) Representative tumors. Scale, 1 mm. (B) The weight of plugs (n = 7 for each group). ***p < 0.001 compared
with As-T alone control group.
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promote angiogenesis than that of B2B cells
(Figure 3F). Overall, the results strongly indicate that
secretory factor(s) released by As-T cells mediates the
communication between As-T cells and vascular
endothelial cells to promote vascular endothelial cell
proliferation and angiogenesis.

found that IL-8 was one of the most significantly
upregulated angiogenic factors in the CM of As-T cells
compared with CM of B2B cells (data not shown). IL-8
has been demonstrated to play an important role in
tumor angiogenesis by directly promoting endothelial
cell survival and proliferation [24]. To verify the result
of IL-8 expression level in CM of As-T by
Angiogenesis Protein Array, we demonstrated that
protein level of IL-8 in the CM from As-T cells was
dramatically increased to more than 100-fold compared
to that from parental B2B cells using ELISA assay
(Figure 4A). Accordingly, the expression of IL-8 in AsT cells was significantly increased at both mRNA
(Figure 4B) and protein (Figure 4C and 4D) levels.
Together, these results suggest that As-T cells express a
higher level of IL-8 and thereby secrete more IL-8 into

As-T cells released higher level of IL-8, which
activated the IL-8 pathway in endothelial cells via
the paracrine effect
To identify angiogenic inducer(s) in the CM of As-T
cells compared to parental B2B cells, we compared the
differential expression levels of factors in CM prepared
from As-T and B2B cells using Angiogenesis Protein
Arrays (RayBiotech, Peachtree Corners, GA, USA). We

Figure 2. As-T cells increased cell migration and proliferation of human umbilical vein cells (HUVECs) and HMVECs. HUVECs
or HMVECs were transduced by lentivirus expressing GFP and selected with puromycin. The GFP-positive HUVECs or HMVECs were then cocultured with B2B or As-T cells in a 1:1 ratio. (A) The growth curve of HUVECs was plotted by counting the GFP-positive cells on indicated
days. ***p < 0.001 compared to B2B+HUVEC group. (B) When reached about 100% confluence, the cells were starved overnight and a
scratch wound was made with a 200 µL pipet tip. Cells were washed using PBS three times and 2 mL fresh basic EBM2 medium was added
to the wells. The width of the wound was measured at 0 h and 20 h post scratch. Images were acquired at 10× magnification, bar = 100 µm.
Left panel: representative images; right panel: quantification of wound healing closure from three experiments. ***p < 0.001 compared to
B2B+HUVEC group. (C) The growth curve of HMVECs was plotted by counting the GFP-positive cells on indicated days. ***p < 0.001
compared to B2B+HMVEC group. (D) The wound healing assay for HMVEC cells was performed as described above. Images were acquired
at 10× magnification, bar = 100 µm. ***p < 0.001 compared to B2B+HMVEC group.
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Figure 3. Vascular endothelial cells cultured in conditioned medium (CM) from As-T cells showed higher cell viability, more
cell migration, and better tube formation. (A) HUVECs were incubated with the CM from B2B or As-T cells for 4 days. Cell proliferation

of HUVECs was determined by counting the number of trypan blue negative cells. ###p < 0.001 compared to complete EBM2 medium group;
< 0.001 compared to B2B CM group. (B) When reached about 100% confluence, HUVECs were starved overnight, and a scratch wound
was made as above. Superannuant was removed, and the CM from B2B or As-T cells was added to the wells. The widths of the wounds
were measured at 0 h and 20 h post scratch. Images were taken using an inverted microscope at 10× magnification, bar = 100 µm. Left
panel: representative images; right panel: quantification of the wound healing assay. ***p < 0.001 compared to CM from the B2B group. (C)
Wound healing assay for the HMVECs was performed as described above. Bar = 100 µm, ***p < 0.001. (D) A transwell assay was conducted
to evaluate the effects of CM on HUVEC migratory ability. HUVECs were plated on the top chamber in 200 μL basic EBM2 medium; the
lower chamber was filled with 600 μL CM from B2B or As-T cells. The cells that pass through the network were stained with crystal violet
and counted under a microscope at 24 h, and the images were taken using a microscope at 10× magnification, bar = 100 µm. Upper panel:
representative images; lower panel: quantification of the migrated cells. ***p < 0.001 compared to CM from B2B cells. (E) Migration assay
for the HMVECs was performed as described above. Bar = 100 µm, ***p < 0.001. (F) A tube formation assay was carried out to evaluate the
effects of CM on the tube forming ability of HUVECs. HUVECs were starved with basic EBM2 medium overnight and resuspended in 100 μL
diluted CM (CM: basic EBM2 = 1:1). The cell suspension was then added to a 96 well-plate containing 100 μL solidified growth factorreduced Matrigel. The tubular structures were imaged at about 6–12 h under a microscope at 4× magnification. Left panel: representative
images of the tubular structures. Middle panel: quantification of the number of the tubular structures. Right panel: quantification of the
length of the tubular structures. *p < 0.05 compared to CM from B2B group.
***p
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the supernatant. Activation of the IL-8/IL8R
signaling pathway plays an important role in
endothelial cell function and angiogenesis. To
investigate whether the secreted IL-8 by As-T cells
activates the IL-8/IL8R signaling pathway in vascular
endothelial cells via a paracrine mechanism, we
found that HUVECs and HMVECs express both
CXCR1 (IL-8RA) and CXCR2 (IL-8RB, Figure 4E).
Treatment with CM of As-T led to the activation of
several downstream targets of the IL-8/IL8R
signaling pathway, including p-mTOR, p-STAT3,
and p-ERK (Figure 4F) in HUVEC cells. These
results demonstrate that compared to parental B2B
cells, As-T cells produce much higher level of IL-8
and secret it into supernatant to activate IL-8/IL8R
signaling pathway in vascular endothelial cells, thus
promoting angiogenesis through the paracrine effect.

receptors on vascular endothelial cells. Tube formation
assay results showed that compared to IgG treatment,
CM from As-T cells treated with IL-8 neutralizing
antibody impeded the tube formation capacity of
HUVECs with 40% to 50% of inhibition (Figure 5A),
indicating that secreted IL-8 by As-T cells contributes
to angiogenesis. To further investigate whether IL-8
generation in As-T cells is required for As-T cellinduced angiogenesis in vivo, we used siRNA against
IL-8 to knock down IL-8 expression in As-T cells and
performed angiogenesis assay using CAM model. The
results showed that compared to scrambled control
siRNA (siCtrl), IL-8 silencing in As-T cells
significantly inhibited angiogenesis by 50% with fewer
branches of microvessels (Figure 5B), indicating that
IL-8 is indispensable in the As-T cells to induce
angiogenesis.

IL-8 generated by As-T cells was required for
angiogenesis in vitro and in vivo

IL-8 knockout in As-T cells impeded vascular
endothelial cell proliferation, migration, and tube
formation

Next, in order to determine whether IL-8 generated by
As-T cells is necessary for promoting angiogenesis, we
added an anti-IL-8 neutralizing antibody into CM of AsT cells that interfered with the binding of IL-8 to its

To investigate how cellular IL-8 in As-T cells regulates
the biological function of vascular endothelial cells, we
knocked out (KO) IL-8 expression in As-T cells using

Figure 4. As‐T cells released higher level of IL‐8, which activated the IL‐8 pathway in endothelial cells via the paracrine
effect. (A) The protein levels of IL‐8 in CM from B2B and As‐T cells were measured using ELISA assay. ***p < 0.001 compared to B2B cells.
(B) The mRNA level of IL‐8 was measured using qRT‐PCR. ***p < 0.001 compared to B2B cells. (C) The protein level of IL‐8 in B2B and As‐T
cells was determined using immunoblotting assay. (D) Quantification of the immunoblotting results using Image Lab software. ***p < 0.001
compared to B2B. (E) The protein expression of IL‐8 receptors, CXCR1 and CXCR2, in HUVECs (left) and HMVECs (right) was determined
using immunoblotting assay. (F) HUVECs were starved overnight and then treated with CM from B2B or As‐T cells for 6 h. The expression of
IL‐8/IL‐8R signaling pathway molecules, p‐mTOR, mTOR, p‐STAT3, STAT3, p‐ERK, ERK, and β‐actin was analyzed using immunoblotting assay.
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the CRISPR/Cas9 technique and evaluated its effect on
endothelial cell proliferation and migration. The
complete depletion of IL-8 was confirmed by
immunoblotting assay (Figure 6A). IL-8 in the CM
from the two IL-8 KO cell lines was almost abolished
compared to the As-T Ctrl cells using ELISA assay
(Figure 6B). Co-culture of HUVECs with IL-8-null AsT cells resulted in a significantly decreased cell
proliferation rate of HUVEC compared to the co-culture
with wild type As-T cells (Figure 6C). Similar results
were observed in HMVECs co-cultured with IL-8-null
As-T cells (Figure 6D). CM from IL-8 KO cells
dramatically reduced the viability of HUVECs (Figure
6E) and HMVECs (Figure 6F) to 50% to 60%
compared to that from control cells. We then performed
a transwell assay to evaluate the effects of secreted IL-8
on vascular endothelial cell migratory ability. As we
expected, significantly fewer HUVECs (Figure 6G) and
HMVECs (Figure 6H) passed through the mesh when
the lower chamber was filled with CM from IL-8-null
As-T cells. The tube formation ability of HUVECs was
dramatically compromised when the cells were cultured

in the CM from IL-8-depleted cells, as the number and
length of the tubular structures were attenuated to 2040% compared to control (Figure 6I). These results
suggest that IL-8 in As-T cells is required to secrete to
the supernatant to promote vascular endothelial cell
growth, migration, and tube formation under the coculture condition.
IL-8 knockout in As-T cells attenuated tumor
growth and angiogenesis using HMVEC/As-T coimplantation animal model
In order to investigate whether IL-8 knockout in As-T
cells affects tumor growth and angiogenesis by
interfering with the crosstalk between As-T cells and
vascular endothelial cells, we performed a tumor growth
assay using HMVEC/As-T co-implantation animal
model. The HMVECs and wild type control or IL-8-null
As-T cells were mixed with Matrigel, then injected into
both flanks of nude mice. The results showed that after
six weeks, co-implantation of HMVECs with IL-8-null
As-T cells resulted in less tumor growth and showed

Figure 5. IL-8 generated by As-T cells was required for angiogenesis in vitro and in vivo. (A) IgG or anti-IL-8 neutralizing antibody
was added to the CM of As-T cells and incubated for 30 min, then the CM was mixed with starved HUVECs in basic EBM2 in a 1:1 ratio to
perform the tube formation assay as described above. The images of the tubular structures were captured 6–12 h later using an inverted
microscope at 4× magnification. Left panel: representative images of the tubular structures. Middle panel: quantification of the number of
the tubular structures. Right panel: quantification of the length of the tubular structures. *p < 0.05 compared to IgG control. (B) IL-8 was
knocked down in As-T cells by transfection of siRNA against IL-8, and angiogenesis assay was performed to evaluate the effects of IL-8
silencing on angiogenesis using CAM model. Left panel: representative plugs from siRNA scrambled control (siCtrl) and siIL-8 groups. Scale is
2 mm. Right panel: the number of blood vessel branches was counted from eight replicates and normalized to that of the control group. **p
< 0.01 compared to the siCtrl group.
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Figure 6. IL-8 knockout in As-T cells impeded vascular endothelial cell proliferation, migration, and tube formation. We
generated As-T IL-8 knockout (KO) and control (Ctrl) stable cells using the CRISPR/Cas9 technique. (A) Complete depletion of IL-8 in As-T cells
was confirmed using immunoblotting assay. (B) The protein levels of IL-8 in the CM from As-T Ctrl and two IL-8 KO stable cell lines were
measured using ELISA assay. (C and D) GFP-positive HUVECs (C) or HMVECs (D) and As-T Ctrl or IL-8 KO cells were mixed in a 1:1 ratio and
seeded into 6-well plates. The number of GFP-positive cells was counted on indicated days. ** and ***p < 0.01 and p < 0.001, respectively,
compared to the As-T Ctrl group. (E and F) HUVECs (E) or HMVECs (F) were incubated with the CM from As-T Ctrl and IL-8 KO cells for 4 days.
The cell viability was determined by counting the number of trypan blue negative cells. ** and ***p < 0.01 and p < 0.001, respectively, compared
to the CM from As-T Ctrl group. (G and H) Transwell migration assays were performed to evaluate the effects of IL-8 KO on HUVECs (G) or
HMVECs (H) migratory ability. HUVECs or HMVECs were plated on the top chamber in 200 μL basic EBM2 medium; the lower chamber was
filled with 600 μL CM from As-T Ctrl or IL-8 KO cells. The cells that passed through the membrane were stained with crystal violet and counted
under the microscope after 24 h. The images were taken at 10× magnification. Upper panel: representative images; bottom panel:
quantification of migrated cells. **p < 0.01 compared to the wild type As-T Ctrl group. (I) A tube formation assay was performed using the CM
from control and IL-8-null cells as described above. The images of the tubular structures were taken using an inverted microscope at 4×
magnification. Left panel: representative images of the tubular structures. Middle panel: quantification of the number of the tubular structures.
Right panel: quantification of the length of the tubular structures. ** and ***p < 0.01 and p < 0.001, respectively, compared to CM from wild type
As-T Ctrl cells.
www.aging-us.com
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smaller size and less weight of xenografts when
compared to co-implantation with wild type As-T cells
(Figure 7A–7C). We also test microvessels by
immunohistochemical staining of CD31. IL-8 knockout
in As-T cells dramatically inhibited angiogenesis with
about 60% decrease of CD31 positive microvessels
(Figure 7D). Consistent with these results, when
compared to co-implantation with As-T mock control
cells, HMVECs co-implanted with As-T-siIL-8 cells
significantly suppressed tumor growth using chimeric
tumor model as shown in Figure 1 (Supplementary
Figure 2). The in vivo study demonstrates that IL-8 in
As-T cells is important for tumor growth and
angiogenesis by interacting with vascular endothelial
cells and maintaining the tumor microenvironment.

attenuated when CXCR1 and CXCR2 on HUVECs were
blocked by their chemical inhibitors, Reparixin and
SB225002, respectively, and SB225002 exhibited a stronger
inhibitory effect than Reparixin (Figure 8B). These results
indicate that secreted IL-8 induces angiogenesis through
binding to vascular endothelial CXCR1 and CXCR2.

DISCUSSION
Among all the tumor microenvironmental cells,
vascular endothelial cells are important for tumor
angiogenesis, which is required for diffusion exchange
of nutrients and metabolites to maintain tumor growth
and promote cancer development and treatment
resistance. It has been reported that the crosstalk
between tumor cells and surrounding endothelial cells
promotes angiogenesis and tumor growth in head and
neck cancer, breast cancer, and liver cancer [26].
Arsenic is an important environmental carcinogen that
causes several types of cancer. Previous studies
including ours have demonstrated that long-term
exposure to a low dose of arsenic leads to malignant
transformation of human normal bronchial epithelial
cells, and these arsenic transformed cells possess
cancerous characteristics [14, 27–29]. Wang et al. have
shown that arsenic-transformed human bronchial
epithelial cells (HBECs) undergo epithelial-tomesenchymal transition (EMT), which promotes

IL-8 receptors in vascular endothelial cells were
required for angiogenesis
To further determine whether IL-8 secreted from
transformed cells stimulates angiogenesis through a
paracrine mechanism, we blocked two IL-8 receptors in
HUVECs using both the neutralizing antibodies and
chemical inhibitors. Tube formation assay showed that the
number and length of the tubular structures formed by
HUVECs were significantly inhibited by more than 50%
when IL-8 receptors CXCR1 and CXCR2 were blocked by
corresponding neutralizing antibodies (Figure 8A).
Consistently, the formation of tubular structures was also

Figure 7. IL-8 knockout in As-T cells attenuated tumor growth and angiogenesis using HMVEC/As-T co-implantation animal
model. IL-8 was knocked out in As-T cells using the CRISPR/Cas9 technique. The HMVEC cells (0.9 × 106) were mixed with wild type Ctrl or

IL-8 KO As-T cells (0.1 × 106) in basic EBM2 medium and then mixed with 1:1 (v/v) growth factor-reduced Matrigel. The cell suspension was
subcutaneously injected into flanks of nude mice at 6 weeks of age. The tumors were harvested 6 weeks after the implantation. (A)
Representative tumors were shown. (B) The size of tumors. *p < 0.05 compared to the As-T Ctrl+HMVECs group. (C) The weight of the
tumors. *p < 0.05 compared to the As-T Ctrl+HMVECs group. (D) IHC staining of CD31 in tumors. Left panel: representative images of IHC
staining. Scale, 50 µm. Right panel: quantification of the microvessel structures in the IHC images. ***p < 0.001 compared to the Ctrl group.
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angiogenesis via activating the β-catenin/VEGF
pathway [14]. We and other researchers have shown
that arsenic exposure promotes angiogenesis and tumor
growth [30–32]. However, how the arsenic-transformed
cells regulate angiogenesis through communication with
vascular endothelial cells is largely unknown. In this
study, we found that crosstalk between As-T cells and
human dermal vascular endothelial cells dramatically
promoted tumor growth compared to As-T cells alone,
confirming the important effect of vascular endothelial
cells in tumor microenvironment on tumor growth.

we used Angiogenesis Protein Arrays to analyze the
differential protein profile in conditioned media from
As-T and parental B2B cells, and found that IL-8 was
one of the most significantly upregulated angiogenic
factors. IL-8 is a pro-inflammatory factor that belongs
to the CXC subfamily of chemokines and functions as
an important regulatory factor of the tumor
microenvironment [19]. IL-8 secretion is induced by
various environmental stress such as hypoxia,
chemotherapeutic reagents, and heavy metals [35]. It is
produced by a variety of cancer cells, leukocytes, and
fibroblasts [35] to promote tumor cell proliferation,
invasion, and metastasis [36, 37]. Arsenic has been
shown to induce upregulation of IL-8 in kidney cells
[20], arsenic-transformed urothelial cells [21], and
arsenic-transformed HBECs [22]. Tumor cell-derived
IL-8 can stimulate cancer cell proliferation and
migration via the autocrine mechanism; and promote
the growth and angiogenic ability of endothelial cells
and the recruitment of neutrophils to the tumor site via
the paracrine mechanism [38, 39]. To investigate the
role and mechanism of IL-8 in As-T cells on mediating

Many angiogenic factors, including VEGF, bFGF,
TGF-α, TGF-β, TNF-α, platelet-derived endothelial
growth factor (PDEGF), granulocyte colony-stimulating
factor (GM-SF), placental growth factor, IL-8, and
epidermal growth factor, promote the process of
angiogenesis [33], and these angiogenic activators play
important roles in the growth and spread of tumor cells
[34]. In order to determine the most important
angiogenic factor in mediating tumor angiogenesis
through As-T and vascular endothelial cell interaction,

Figure 8. IL-8 receptors in vascular endothelial cells were required for angiogenesis. (A) HUVECs were starved overnight and

resuspended in basic EBM2 medium supplemented with IgG or anti-CXCR1 or anti-CXCR2 neutralizing antibodies for 30 min. Then the cells
were mixed with CM from As-T cells in a 1:1 ratio and plated in 96 well plates pre-coated with solidified growth factor-reduced Matrigel for
tube formation assay. The tubular structures were imaged at 6–12 h at 4× magnification. Left panel: representative images of the tubular
structure. Middle panel: the number of tubular structures was measured. Right panel: the length of the tubular structures was measured.
*p < 0.05 compared to the IgG control group. (B) HUVECs were starved overnight. The cells were then treated with DMSO, Reparixin (CXCR1
inhibitor), or SB225002 (CXCR2 inhibitor) for 2 h. The tube formation assay was performed as above. The tubular structures were imaged at
6–12 h using a microscope at 4× magnification. Left panel: the representative images of the tubular structure. Middle panel: quantification
of the number of the tubular structures. Right panel: quantification of the length of the tubular structures. * and **p < 0.05 and p < 0.01,
respectively, compared to the DMSO treatment control group.
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vascular endothelial functions and angiogenesis by
crosstalk, we found that interaction between As-T and
vascular endothelial cells HUVECs and HMVECs
promoted vascular endothelial cell proliferation and
migration. In consistent with previous studies showing
the angiogenic role of IL-8 in the endothelial cell [24,
40], we found that compared to parental normal bronchial
epithelial cells B2B, malignant As-T cells produced a
very high level of IL-8 to secrete into the supernatant,
which activated IL-8/IL-8R signaling in vascular
endothelial cells through a paracrine mechanism to
enhance cell viability, migration, and tube formation.
Furthermore, IL-8 neutralizing antibody or siRNA
against IL-8 in As-T cells dramatically inhibited
angiogenesis in vitro and in vivo. IL-8 KO in As-T cells
further abolished the capacities of cell viability,
proliferation, migration, and tube formation of vascular
endothelial cells via the paracrine effect, and markedly
suppressed tumor growth and tumor angiogenesis using
HMVEC/As-T co-implantation animal model. These
results are consistent with previous results in colon
cancer, glioblastoma, and ovarian cancer, in which IL-8
has been demonstrated to promote angiogenesis and
tumor growth both in vitro and in vivo [41]. As far as we
know, this is the first report to reveal that secreted IL-8
by As-T cells promotes tumor growth and angiogenesis
through crosstalk with vascular endothelial cells via its
paracrine mechanism.

In summary, we found that arsenic transformed cells
produced and secreted very high level of IL-8 to induce
tumor growth and angiogenesis through As-T and
vascular endothelial cell communication. IL-8 is one of
the key angiogenic factors to promote tumor
angiogenesis via the paracrine mechanism in As-T cells.
The results from this study will extend our
understanding of the mechanisms of lung cancer caused
by long-term arsenic exposure and will provide
potential targets for anti-angiogenesis therapies and
cancer
prevention
by
modulating
tumor
microenvironment in metal-induced carcinogenesis in
the future.

MATERIALS AND METHODS
Cell culture and reagents
B2B cells were obtained from American Type Culture
Collection (ATCC, Manassas, VA, USA). B2B cells
were transformed into As-T cells by exposure to 1 µM
sodium arsenic for 6 months as we previously
described, which act like lung cancer cells and can form
tumors in nude mice [29]. Passage-matched B2B cells
were used as parental control cells. B2B and As-T cells
were cultured in DMEM (Dulbecco’s modified Eagle’s
medium; Invitrogen, Carlsbad, CA, USA) supplemented
with 10% fetal bovine serum (FBS) and 50 U/ml
Penicillin-Streptomycin. Human umbilical vein
endothelial cells (HUVEC) and human dermal
microvascular endothelial cells (HMVEC) were
obtained from Lonza (Lonza, Hayward, CA, USA) and
cultured in endothelial basal medium-2 (EBM-2)
complete medium (Lonza). Cells were incubated at
37°C in a humidified atmosphere of 5% CO2 in the air.

IL-8 exerts its biological effects through binding to two
types of cell-surface G protein-coupled receptors,
CXCR1 and CXCR2 [42]. Upon IL-8 binding to its
receptors, it activates the IL-8/IL-8R signaling pathway
to induce the activation of the mitogen-activated protein
kinase (MAPK)/ERK1/2 [43, 44], STAT3 [45, 46], and
PI3K/AKT/mTOR signaling pathways [47]. These
signaling pathways play important roles in cell
proliferation, apoptosis, migration, invasion, and
angiogenesis. In this study, we found that HUVECs and
HMVECs expressed both CXCR1 and CXCR2, which
is consistent with the previous study, showing that
HUVEC and HMEC cells express CXCR1 and CXCR2
protein [24]. When we cultured HUVECs in CM from
As-T cells, HUVECs showed increased phosphorylation
of mTOR, STAT3, and ERK1/2, indicating upregulated
IL-8 by As-T cells can effectively activate the IL8/CXCR1/2 signaling pathway in vascular endothelial
cells. Next, in order to study whether endothelial
CXCR1 and CXCR2 are necessary for As-T cellsinduced angiogenesis through the paracrine effect,
blocking the binding of IL-8 to its receptor using
neutralizing antibodies and chemical inhibitors showed
a significant inhibitory effect on tube formation, suggest
that IL-8 in As-T cells induces cellular function of
vascular endothelial cells to promote angiogenesis
through binding to the IL-8 receptors.
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Transient transfection
As-T cells were cultured to 60% to 70% confluence in
35-mm dishes. The cells were transfected with 100 nM
small interfering RNA (siRNA) oligos targeting human
IL-8 (siIL-8) or scrambled control siRNA (siCtrl) using
the jetPRIME reagent according to the manufacturer’s
instruction.
Establishment of IL-8 knockout (KO) stable cells
IL-8 was completely knocked out from As-T cells using
the CRISPR/Cas9 technique. The lentivirus carrying
Cas9 from Dharmacon (CAS10138, Lafayette, CO,
USA) was packaged in 293T cells following the
manufacturer’s instruction. The supernatants containing
the virus were collected at 48, 60, and 72 h after
transfection, and the viral soup was used to infect As-T
cells in the presence of polybrene (10 μg/ml). After 72
h, blasticidin (1.5 μg/ml) was used to select cells stably
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expressing Cas9. The lentivirus carrying control sgRNA
or IL-8 sgRNA (Abm, Richmond, Canada) was
packaged in 293T cells as described above. The Cas9expressing As-T cells were transduced with a viral soup
containing the control or IL-8 sgRNA and then selected
with G418 (100 μg/ml). The KO of IL-8 was confirmed
using an immunoblotting assay.

dry milk for 2 h and then incubated with the following
primary antibodies: IL-8 (1:1000, Cell Signaling), CXCR1
(1:1000, Abcam), CXCR2 (1:1000, Abcam), mTOR
(1:1000, Cell Signaling), p-mTOR (1:1000, Cell
Signaling), STAT3 (1:1000, Cell Signaling), p-STAT3
(1:1000, Cell Signaling), ERK (1:1000, Cell Signaling), pERK (1:1000, Cell Signaling), and β-actin (1:1000, Santa
Cruz) overnight at 4°C. The membranes were then
incubated with anti-rabbit or anti-mouse secondary
antibodies (1:1000, Invitrogen) for 1 h at room temperature
after three washes with PBST. The protein bands were
visualized with enhanced chemiluminescence reagent
(Thermo Scientific, Rockford, IL, USA), and images were
acquired with a ChemiDoc Imaging System (Bio-Rad, CA,
USA). Quantification of the immunoblotting results was
performed using the Image Lab software (Bio-Rad, CA,
USA).

Vascular endothelial cells stably expressing eGFP
Lentivirus harboring an eGFP coding cassette
(Transomics, Huntsville, AL, USA) was packaged in
293T cells as described above. HUVECs or HMVECs
were transduced by lentiviral soup and selected by
puromycin (1.0 μg/ml) to establish stable cells
expressing the GFP protein.
Isolation of total RNAs, RT-PCR, and qRT-PCR
analysis

Wound healing assay
HUVECs or HMVECs alone or mixed with B2B or AsT cells at a 1:1 ratio were cultured until they reached
almost 100% confluence in 6-well plates. The cell
monolayer was scratched using a 200 µL pipette tip.
The cells were washed twice with PBS to remove
debris, and the wound was imaged at 0 h and 20 h using
a Nikon ECLIPSE Ts2R microscope (Nikon, Japan).
The average percentage of wound healing was
determined based on measurements of three sites of the
wound area.

Total RNAs were extracted from cultured cells using
TRIzol reagent (Invitrogen, Carlsbad, CA, USA). To
determine the mRNA expression of IL-8, 1.0 µg total
RNA was reverse transcribed to cDNA using the iScript
cDNA synthesis kit (Bio-Rad, CA, USA) according to
the manufacturer’s instruction. The IL-8 mRNA level
was measured using the SYBR green supermix kit (BioRad, CA, USA) according to the manufacturer’s
instruction. GAPDH was used as an internal control.
The primers were as follows: IL-8 forward primer, 5′-G
AGAGTGATTGAGAGTGGACCAC-3′; IL-8 reverse
primer,
5′-CACAACCCTCTGCACCCAGTTT-3′;
GAPDH
forward
primer,
5′-TGTTGCCATCA
ATGACCCCTT-3′; GAPDH reverse primer, 5′-CTC
CACGACGTACTCAGCG-3′. The fold changes were
calculated with the 2–ΔΔCt method.

Transwell migration assay
Transwell chambers (from BD Biosciences, Bedford,
MA and Costar, Corning Inc., Corning, NY, USA) with
8-μm pores on the membrane were inserted into 24-well
plates. About 3.0 × 104 HUVECs or HMVECs in 200
µL basic EBM2 medium (without growth factors and
serum) were seeded onto each upper well of transwell
chambers. The lower chamber of the transwell device
was filled with 600 μL conditioned medium. After
incubation for 24 h at 37°C, cells that did not migrate
through the membrane were removed from the top well
using a cotton swab. Cells that had migrated through the
membrane were fixed with 20% methanol and stained
with 0.1% crystal violet (Sigma, Saint Louis, MO,
USA), imaged, and counted. The images were acquired
with a Nikon ECLIPSE Ts2R microscope (Nikon,
Japan). Three independent experiments were conducted
in triplicate.

ELISA assay
ELISA assay for determining IL-8 concentration in the
conditioned medium of cells was performed using a
human IL-8 ELISA kit according to the manufacturer’s
instruction (D8000C, R&D Systems, Minneapolis, MN,
USA). Optical densities were read at 405 nm on a
microplate reader.
Immunoblotting assay
Total cellular protein extracts were prepared using the
RIPA buffer supplemented with protease and phosphatase
inhibitors. Protein concentrations were determined using a
BCA assay (Thermo Scientific, Philadelphia, PA, USA).
Aliquots of 20 μg protein lysates were fractionated by 10%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
and transferred to a nitrocellulose membrane (Roche,
Switzerland). Membranes were blocked with 5% non-fat
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Tube formation assay
Tube formation assay (angiogenesis assay in vitro) was
performed as we previously described [16]. In brief,
HUVECs were cultured in EBM-2 basal medium
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with 0.1 × 106 wild type control or IL-8-null As-T cells
and then mixed with growth factor reduced Matrigel
(BD, USA) in 1:1 (v/v) ratio. The mixtures were
injected subcutaneously into both sides of the posterior
flank of five nude mice in each group. Forty-five days
later, all mice were sacrificed, and tumors were
harvested. The long and short dimensions of the tumors
were measured, and tumor sizes were calculated by the
formula: volume (mm3) = [width2 (mm2) × length
(mm)]/2. Part of the tumors was snap-frozen and stored
at −80 degrees for later use; part of the tumors was
formalin-fixed, paraffin-embedded, and sectioned at 5
μm for CD31 immunohistochemical staining under the
standard procedure. The images were acquired with the
Nikon ECLIPSE Ci microscope (Nikon, Japan). The
CD31-positive microvessels were quantified. All
procedures were approved by the Animal Care and Use
Committee of Thomas Jefferson University.

containing 0.2% FBS for 24 h before performing the
tube formation assay. The conditioned media were
prepared from different 100% confluent cells using
EBM-2 medium with 1% FBS after culture for 24 h.
The HUVECs were resuspended in EBM-2 basic
medium, mixed with an equal volume of the
conditioned medium, and seeded on Matrigel-pretreated
96-well plates at 2 × 104 cells/well. Tube formation was
observed and photographed after being cultured for
indicated time points under the Nikon ECLIPSE Ci
microscope (Nikon, Japan). The number and lengths of
the tubular structures (the perimeter of each tubular
structure) in each well were measured using the
Angiogenesis Analyzer plugin of Image J (NIH, USA).
Chicken chorioallantoic membrane (CAM) assay for
tumor-induced angiogenesis
The CAM assay is performed as previously described
[48]. White Leghorn fertilized chicken eggs were
incubated at 37°C under constant humidity. An artificial
air sac was created over a region containing small blood
vessels in the CAM. The cells were implanted onto the
CAM. Tumor angiogenesis was analyzed 4 days after
the implantation. The area around the implanted
Matrigel was photographed, and the blood vessel
branches on the CAM were counted by two observers in
a double-blind manner. Ten chicken embryos were used
for each treatment group.

Statistical analysis
All statistical analysis was performed using GraphPad
Prism 8 software (GraphPad Software, Inc., CA, USA).
All the results are expressed as mean ± standard error
(SE) of at least three individual experiments or each
group. The means of two independent groups were
compared using the unpaired Student’s t-test. The
means of more than two groups were analyzed using the
one-way ANOVA test followed by the post hoc
Bonferroni test. The growth curves were analyzed using
the two-way ANOVA test followed by the post hoc
Bonferroni or Dunn test. A P-value less than 0.05 was
considered statistically significant.

Chimeric tumor model to test tumor growth using
chicken CAM
Using chimeric tumor model to test tumor growth on
CAM was performed as previously described [49].
Briefly, poly-l-lactide glycolide acid (PLGA) was used
to make a biodegradable polymer matrix as we
described [49]. White Leghorn fertilized chicken eggs
were incubated at 37°C under constant humidity, and a
small window was cut in the shell over the artificial air
sac. The HMVECs (0.9 × 106) were mixed with 0.1 ×
106 As-T cells and then mixed with 1:1 (v/v) growth
factor-reduced Matrigel (BD Labware, USA). The As-T
cells alone (0.1 × 106) mixed with Matrigel were used
as a control. The cell mixture was seeded into the
PLGA sponges, incubated at 37°C for 30 min, and
transplanted onto CAM. The eggshell window was
resealed, and the chicken embryos were incubated at
37°C for tumor growth. After 12 days, the tumors were
trimmed out from the CAM, photographed, and
weighed.
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SUPPLEMENTARY MATERIALS
Supplementary Figures

Supplementary Figure 1. Medium from As-T cells promoted the transwell migratory ability of HUVEC cells. B2B and As-T cells
were plated on the lower chamber of 24 well-plate. When the cells were confluent, 600 μL 1% FBS supplemented DMEM medium was added
to the wells and incubated for 24 h. The starved HUVEC cells were resuspended in the basic EBM2 medium and plated in the top chamber of
the transwell cassette. The migrated cells were stained and counted at 24 and 48 h. Images were acquired at 10× magnification. (A)
Representative images of migrated cells. (B) Quantification of the migrated cells. ** and ***p < 0.01 and p < 0.001, respectively, compared to CM
from B2B cells.
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Supplementary Figure 2. Silencing IL-8 in As-T cells suppressed the promoting effect of endothelial cells on As-T cellinduced tumor growth. Mock control or siIL-8-transfected As-T cells were mixed with HMVECs in a 1:9 ratio in serum-free medium, and
then the mixed cells were carried by the PLGA sponges for the implantation onto the CAM of 8 days old chicken embryos. The tumors were
harvested 12 days after the implantation. (A) Representative tumors. Scale, 1 mm. (B) The weight of plugs (n = 6 for each group). **p < 0.01
compared with mock As-T+EC group.
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